[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - e-archivo.uc3m.es
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - repository.rcsi.com
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - iris.unito.it
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - core.ac.uk
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - researchgate.net
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - e-archivo.uc3m.es
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
[PDF][PDF] A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
A Hernández-Laın, O Toldos, Y Ruano, L Alcázar… - 2022 - core.ac.uk
We report a medium-throughput drug-screening platform (METPlatform) based on
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …
organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By …